Glenn M. Chertow, MD, MPH

College:	University of Pennsylvania (B.A.)
Medical School:	Harvard Medical School (M.D.)
Other Graduate Training:	Harvard School of Public Health (M.P.H.)
Internal Medicine Residency:	Brigham and Women's Hospital, Boston
Nephrology Fellowship:	Brigham and Women's Hospital, Boston

Interests

Clinical: Hemodialysis, peritoneal dialysis, continuous renal replacement therapy, acute renal failure, chronic kidney disease

Research: Clinical epidemiology, health services research, decision sciences, and clinical trials in acute and chronic kidney disease; kidney disease and cardiovascular disease; nutritional evaluation and nutrition support, intensive care medicine

Scholarly and Creative Activities (selected)

Kurella M, Covinsky KE, Collins AJ, Chertow GM. Octogenarians and nonagenarians starting dialysis in the United States. Ann Intern Med. 2007 Feb 6;146(3):177-83.

Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005 Nov;16(11):3365-70.

Chertow GM. A 43-year-old woman with chronic renal insufficiency. JAMA. 2004 Mar 10;291(10):1252-9.

Chertow GM, Burke SK, Raggi P. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int. 2002 Jul;62(1):245-52.

Chertow GM, Johansen KL, Lew N, Lazarus JM, Lowrie EG. Vintage, nutritional status, and survival in hemodialysis patients. Kidney Int. 2000 Mar;57(3):1176-81.

Chertow GM, Milford EL, Mackenzie HS, Brenner BM. Antigen-independent determinants of cadaveric kidney transplant failure. JAMA.1996 Dec 4;276(21):1732-6.

For more publications: PubMed for Chertow, Glenn